A/Prof Michael Michael
Assoc. Prof Michael is a Gastrointestinal and Neuroendocrine Medical Oncologist, with a significant major track record in academic oncology with considerable expertise in clinical/translational trials and their design. His Medical Oncology training was attained at the Peter MacCallum Cancer Centre, he was a Clinical Fellow to the Department of Medicine at the Princess Margaret Hospital/Ontario Cancer Institute in Toronto, Canada, pursuing his research in gastrointestinal oncology. He was awarded the degree of Doctorate of Medicine (Monash University) in 2009. Assoc. Prof Michael has been the Principal Investigator (institutional/national) and the principal designer/co-designer for several oncology trials. He has significant research interests/expertise in combined modality therapies for GI malignancies including NETs and supervising post-graduate PhD students in translational and clinical studies both in GI and NET oncology.
He co-chairs the PeterMac Neuroendocrine Unit- with a national/international referral base and helped establish the first national NET Clinic at his institution and the development of post-graduate training courses in this area. The Neuroendocrine Unit is currently applying for European Neuroendocrine Tumour Society Centre of Excellence- the first such centre to be located outside Europe.
His research work has generated over 7 million dollars in competitive grant funding and 4 million dollars from industry. He has over 130 publications including high impact peer-reviewed articles, book chapters and reviews, with multiple presentations at local/international conferences and has authored/co-authored over 120 conference abstracts. He has given over 75 invited presentations in local/international forums. Assoc Prof Michael has been a reviewer for numerous international oncology journals and external reviewer for several local and international oncology funding bodies.